Egypt Anti-Fungal Market Analysis

$3,500.00$7,500.00

  • Type: Common Disease Area
  • Published : February 2022
  • Region: Africa
  • Country: Egypt
  • Report ID : 5046

  • Format: PPT, PDF

Egypt Anti-Fungal Market: Segmented by Drug Type, Indication, Route of Administration, Distribution Channel and Application – Growth, Market Size, Future Prospects & Competitive Analysis, 2021–2026

Clear
SKU: 5046 Categories: ,

Report Description of the Egypt Anti-Fungal Market

Research Scope and Assumption

  • The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
  • The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
  • We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
  • All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
  • Inflation has not been accounted for in order to estimate and forecast the market
  • Numbers may not add up due to rounding off

Research Objective:

  • To analyze and forecast the market size of Egypt Anti-Fungal Drugs market
  • To classify and forecast Egypt Anti-Fungal Market Drugs market based on application, drugs, project type, and application.
  • To identify drivers and challenges for Egypt Anti-Fungal Drugs market
  • To examine competitive developments such as mergers and acquisitions, agreements, collaborations and partnerships, etc., in Egypt Anti-Fungal Drugs market
  • To conduct pricing analysis for Egypt Anti-Fungal Drugs market
  • To identify and analyze the profile of leading players operating in Egypt Anti-Fungal Drugs market

Reason to buy the report:

  • Facilitate decision-making based on strong current and forecast data for Anti-Fungal drug market
  • Develop strategies based on the latest regulatory framework
  • Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
  • Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the Anti-Fungal market
  • Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • We have technically sound team which do a deep dive research and also provide strategy-based consulting analysis

Egypt Anti-Fungal Market Executive Summary

Anti-fungal agents are used in the treatment of fungal infections. According to global action fund for fungal infection, globally, over 300 billion people of all ages suffer from a serious fungal infection every year. In next few years, the market of anti-fungal in middle east expected to grow enormously with growing population.

Market Size and Key Findings

The Middle East Anti-Fungal market size is at around USD 4.3 billion in 2020 and is projected to reach USD 1.08 billion in 2021, exhibiting a CAGR of 3.462% during the forecast period.

The middle east Anti- Fungal Market, in the next few years is expected to grow enormously with the growing global population. Increase in the prevalence of fungal infection has prompted to manufactures to develop advanced formulation medication for better clinical outcomes. This in turn is propelling the growth of the market during the forecast period.

Market Dynamics

Market Growth Drivers Analysis

The market drivers include rising prevalence of fungal infections, rising awareness, rise of immunity deficient population such as geriatrics, rise in exposure to infectious agents due to environmental factors such as pollution especially by particulates and agriculture residues and climatic conditions such as humidity and temperature, occupational hazards such as Jock itch, crowding etc. Growth of fungal infection due to off label use of broad-spectrum antibiotics is a prime factor for the growing market for anti-fungal agents. Also, the rising population with a weak immune system, in whom fungal infections are much more than average, will drive the market. The high prevalence of conventional drugs used for the treatment of fungal infections is significantly restraining market growth.

Market Restraints

The market restraints include rising resistance to anti-fungal agents, use of air filters and air conditioning, excellent spectrum and efficacy of Azole class of anti-fungal agents, loss of patents and generalization etc. Competition by generics is exceptionally strong and generics account for roughly 50% of total sales for anti-fungal agents. The market penetration is very easy as there has been loss of patents of blockbuster drugs. Over-the-counter drugs are an important reason for the growth of the anti-fungal agents market.

COVID-19 impact on “Egypt Anti-Fungal Market” 

29 billion in 2021 at a compound annual growth rate (CAGR) of 3.1%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $13.71 billion in 2025 at a CAGR of 7.4%

Competitive Landscape

Key Players

Some of the key players in this market are: Novartis AG, Pfizer, Inc., Sanofi-Aventis, Merck & Co., Inc., Enzon Pharmaceuticals, Inc., Bayer AG, Astellas Pharma, Inc., GlaxoSmithKline plc, Abbott, Sigma-Aldrich and others.

Products in Pipeline

While a new antifungal have been approved in decades, a number of drugs are undergoing clinical trials. These medicines in the pipeline involve new pathways or chemical modificationsto existing drugs. Their developers hope these inventions or modifications will help sidestep current problems with toxicity or fungal resistance. These new genertion therapy includes -Fosmanogepix, Olorfim,Ibexafungrep, Rezafungin, Oteseconazole and VT-1598.

Notable Recent Deals

Pfizer Inc. (NYSE: PFE) announced that it has acquired Amplyx Pharmaceuticals, Inc., a privately-held company dedicated to the development of therapies for debilitating and life-threatening diseases that affect people with compromised immune systems. Amplyx’s lead compound, Fosmanogepix (APX001), is a novel investigational asset under development for the treatment of invasive fungal infections.

Healthcare Policies and Regulatory Landscape

Pricing and Reimbursement scenario of Anti-Fungal Drug

There is moderate concern among payers regarding spend on anti-Fungal drugs, but access restrictions remain mild. The expenditures related to the use of antifungal drugs per febrile neutropenic episode were $3,857.85 for VOR; $15,783.34 for caspofungin, and $21,561.02 for L-AmB, respectively. The expenditure related to the use of posaconazole (POS) was $32,167.39 per patient for primary or secondary prophylaxis. Currently, price-controlled antifungal drugs are less commonly used by practitioners. This shows the need to bridge the gap between policy makers and health-care service providers to help the ailing population.

1. Report Description of the Egypt Anti-Fungal Market
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. Egypt Anti-Fungal Market Executive Summary
2.1 Global RCC Drug Market – Industry Snapshot & key buying criteria, 2020-2028
2.2 Market Size, Growth Prospects and Key findings
3. Market Dynamics of Egypt Anti-Fungal Market
3.1 Market Growth Drivers Analysis
3.1.1 Increasing prevalence of Fungal infections
3.1.2 Increasing Awareness on Fungal Infections
3.1.3 Raising Immunity Deficient Population
3.1.4 Label Use of Broad-Spectrum Antibiotics
3.2 Market Restraints Analysis
3.2.1 Rising Resistance to Anti-Fungal Agent
3.2.2 Medical Conditions
3.2.3 Side Effects of Anti-Fungal Agent
3.3 Covid-19 Market Impact Analysis
3.3.1 Negative impact on outcomes
4. Fungal infection treatment Market Segmentation
4.1 By Drugs Analysis
4.1.1 Azoles
4.1.2 Echinocandins
4.1.3 Polienes
4.1.4 Allylamines
4.2 By Indication Analysis:
4.2.1 Dermatophytosis
4.2.2 Aspergillosis
4.2.3 Candidiasis
4.3 By Route of Administration Analysis:
4.3.1 Oral
4.3.2 Topical
4.3.3 Parenteral
4.4 By Distribution Channel Analysis:
4.4.1 Hospitals and Pharmacies
4.4.2 Retail Pharmacies and Drug stores
4.4.3 Online Pharmacies
4.5 By Application Analysis:
4.5.1 Ointments
4.5.2 Powder
4.5.3 Drugs
4.5.4 Pastes
5. Anti-Fungal Major Products Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape
6.1 Products in Pipeline
6.2 R&D Initiatives in Egypt Anti-Fungal Market
6.3 Notable recent deals in Egypt Anti-Fungal Drugs Market
6.3.1 Joint Ventures
6.3.2 Partnerships
6.3.3 Mergers & Acquisitions
6.3.4 Strategic divestments
7. Key Company Profiles
7.1 Novartis AG Overview
Product & Services, Strategies & Financials
7.2 Pfizer, Inc.Company Overview
Product & Services, Strategies & Financials
7.3 Sanofi-Aventis Company Overview
Product & Services, Strategies & Financials
7.4 Merck & Co., Inc. Company Overview
Product & Services, Strategies & Financials
7.5 Enzon Pharmaceuticals, Inc. Company Overview
Product & Services, Strategies & Financials
7.6 Bayer AG Company Overview
Product & Services, Strategies & Financials
7.7 Astellas Pharma, Inc. Company Overview
Product & Services, Strategies & Financials
7.8 GlaxoSmithKline plc Company Overview
Product & Services, Strategies & Financials
7.9 Abbott Company Overview
Product & Services, Strategies & Financials
7.10 Sigma-Aldrich Company Overview
Product & Services, Strategies & Financials
7.11 Enzon Pharmaceuticals, Inc. Company Overview
Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape
8.1 Pricing and Reimbursement scenario of Egypt Anti-Fungal Drugs
8.2 Government Initiatives / Intervention programs
9. Factors Driving Future Growth
9.1 New Trends and Development of Egypt Anti-Fungal Drugs market
9.2 Future Opportunities
10. Strategic Recommendations

Anti-Fungal Market Segmentation

Drug Type:

Based on the drug type, the market is segmented into azoles, echinocandins, polyenes, and allylamines. Azoles are considered to be the leading segment owing to its fungicidal properties and increased revenue generation in 2019. Azoles are systemic antifungal drugs that include fluconazole, ketoconazole, and others which are highly recommended for fungal infection treatment, thereby upscaling the market.

  • Azoles
  • Echinocandins
  • Polyenes
  • Allylamines

By Indication:

In terms of indication, the market is segmented into dermatophytosis, aspergillosis, candidiasis, and others. Dermatophytosis is a non-fatal superficial infection on skin. Dermatophytosis is anticipated to dominate the market owing to an increase in prevalence of dermatophytosis cases.

  • Dermatophytosis
  • Aspergillosis
  • Candidiasis
  • Others

By Route of Administration:

In terms of route of administration, the market is segmented into oral, topical and parenteral. Among these, the topical antifungal route of administration holds the largest antifungal drugs market share owing to an increase in the adoption of topical drugs globally.

  • Oral
  • Topical
  • Parenteral

By Distribution Channel:

Based distribution channel, results regular hospital visits obtaining advanced for the pharmacies & also anticipated emerge as the fastest-growing segment the market. the rise the drug supply medical professionals, healthcare centers, and others. addition an increase the number patients for non-prescription drugs, and convenience drug, others are propelling the of pharmacies during the forecast period.

  • Hospitals and clinics
  • Retail Pharmacies and Drug stores
  • Online Pharmacies

By Application:

Based on the application Anti-Fungal Drug market has sub segmented into:

  • Ointments
  • Powder
  • Drugs
  • Pastes

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.



    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements